Vitamin D is a key player in the endocrine regulation of calcium and phosphate metabolism and plays a pivotal role in the acquisition of bone mass during childhood. This study investigated long-term data of vitamin D levels in children and adolescents between 1 and 18 years of age. 
The importance of vitamin D for skeletal health is well established and its potential role in extraskeletal health has generated much interest in recent years. A recent umbrella review summarized that vitamin D deficiency is linked to an array of chronic diseases, e.g., diabetes, autoimmunity, cancer, and is associated with negative cardiovascular outcomes (Theodoratou et al., 2014) . Data from a large study demonstrated a J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D (25(OH)D), and the lowest mortality risk was at 50-60 nmol/L (Durup et al., 2012) . Vitamin D status is defined by serum 25(OH)D, and a concentration of 50 nmol/L (20 ng/mL) cover the requirements in 97.5% of the population (Ross et al., 2011) . Solar UV-B radiation is important for endogenous vitamin D synthesis; however, sunlight is limited at the latitude 55-69 during October to March, (van Schoor & Lips, 2011) but Swedish children generally have a high intake of vitamin D from dietary products.
We hypothesized that the generally increased indoor activities would contribute to decreased vitamin D levels in children over the years. The present study provided long-term data of vitamin D levels in a group of children between 1 and 18 years of age referred over 30 years for extensive growth evaluation to Göteborg Pediatric Growth Research Center (GP-GRC), who were diagnosed with short stature due either to idiopathic or organic cause of growth hormone (GH) insufficiency, to decreased GH responsiveness as in children with idiopathic short stature, born small for gestational age or children with syndromes or chronic diseases; and also healthy children with normal or tall stature.
Serum 25(OH)D was analysed between 1982 and 2013 in 2048 Swedish Caucasian children (mean age ± SD, 8.59 ± 3.68 years; 1197 boys) with the IDS-iSYS 25-Hydroxy Vitamin DS automated chemiluminescence immunoassay (Immunodiagnostic Systems Limited, Boldon, UK) at the GP-GRC laboratory (Swedac accredited no. 1899). The intra-assay and interassay coefficients of variation were 2.5% at 50.1 nmol/L and 9.0% at 55.0 nmol/L, respectively. All samples in the present study were stored at − 80°C and assayed with reagents from the same batch in days after each other. In general, serum 25(OH)D is regarded as a stable analyte over time (Bailey et al., 2013; Stepman et al., 2011) , and studies of 40-year-old sera have revealed that 25(OH)D can be quantified to reveal potential trends that can be used to explore vitamin D-related hypotheses (Bodnar et al., 2009 ). Taken together, we conclude that our 25(OH)D levels, sampled over a 30-year period, are reliable even if the possibility exists that the 25(OH)D levels could change during long-term storage never can be ruled out. (Fig. 1, upper panel) . We found a significant association (p b 0.00001) with age independent of gender, i.e., younger children had higher 25(OH)D levels, possibly due to the general supplementation of vitamin D recommended for Swedish infants (Fig. 1, lower Overall, 704 (34%) children had below recommended levels of 50 nmol/L, and 63 (3%) had levels below 25 nmol/L, i.e., vitamin D deficiency (Ross et al., 2011) . Less attention has been given to recommend an upper limit of serum 25(OH)D; however 83 (4%) subjects had 25(OH)D levels above 100 nmol/L of whom 15 (1%) had levels above 125 nmol/L (Ross et al., 2011) .
The presence of 3-epi-25(OH)D, a vitamin D metabolite with reported reduced biological activity, has been reported to be a source of analytical variance in immunoassays (Bailey et al., 2013) . In addition, an age-dependent concentration has also been reported (Stepman et al., 2011) . The cross-reactivity for 3-epi-25(OH)D is approximately 1% in the automated IDS-iSYS immunoassay used in the current study. Thus, due to the low cross-reactivity, we do not believe that potential amounts of 3-epi-25(OH)D overestimates the reported 25(OH)D values in this study.
In conclusion, we found no trend for decreased vitamin D levels over time in this Swedish population. These results will broaden our understanding of the public health relevance of vitamin D and be of value for future cost-benefit analyses in preventive healthcare.
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